Navigation Links
Bionovo to Host Conference Call to Discuss 2011 Highlights and Year-End Financial Results
Date:2/16/2012

EMERYVILLE, Calif., Feb.16, 2012 /PRNewswire/ -- Bionovo, Inc. (OTC Link Platform: BNVI.PK) a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, announced today that it will host a conference call on Tuesday, February 21, 2012 at 1:30 PM PST to discuss its 2011 financial highlights for the year ended December 31, 2011.

(Logo:  http://photos.prnewswire.com/prnh/20111110/SF04662LOGO)

Interested parties can access the call by dialing 877-941-8416, or listen via a live audio only webcast, which can be found at http://bionovo.com/investors/events.  A replay of the call will be available by dialing 1-877-870-5176 (replay code: 4515311) through February 28, 2012 and archived via audio webcast at http://bionovo.com/investors/events.

About Bionovo, Inc.

Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources, which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes it has discovered new classes of drug candidates within its rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and its stock is traded on the OTC Link Platform under the symbol "BNVI.PK." For more information about Bionovo and its programs, visit http://www.bionovo.com.

 

 


'/>"/>
SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Bionovo Announces Third Quarter 2011 Highlights and Financial Results
2. Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
3. Bionovo to Present Tissue Selective Estrogen Receptor Modulators for Obesity at the 22nd Annual Meeting of the North American Menopause Society
4. Bionovo Announces an Additional 180 Day Period to Regain Compliance With Nasdaqs Bid Price Rule
5. CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
6. Bionovo Announces Second Quarter 2011 Highlights and Financial Results
7. Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
8. Bionovo to Announce First Quarter Financial Results on Wednesday, May 11, 2011
9. Bionovo Announces Enrollment Started in the Menerba (MF101) Phase 1 "Tolerability" Clinical Trial for Menopausal Hot Flushes
10. Bionovo Announces 2010 Highlights and Year-End Financial Results
11. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... TUCSON, Ariz. , May 3, 2016  As ... twice contracted rheumatic fever, which damaged his heart. ... But by June 2013, Shepherd,s heart was ... days from death. On June 20, 2013, the ... temporary Total Artificial Heart (TAH-t). Like a heart transplant, ...
(Date:5/3/2016)... LAKE OSWEGO, Ore. , May 3, 2016 /PRNewswire/ ... about the importance of extending care beyond the implant ... Scientific Sessions, May 4-7 in San Francisco ... tasked with continually delivering the highest quality of patient ... ensuring patients are cared for each and every tomorrow," ...
(Date:5/3/2016)... , May 3, 2016  Specialty Silicone ... tool that shows how a cleanroom works. The ... discussions about science and technology. ... "As a technology company, SSF enthusiastically supports the ... help educators foster the next generation of innovators. ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... May 04, 2016 , ... ... interview techniques, seeks to add a deeper understanding of the program, policy or ... and each answers different yet important questions. , In a new brief released ...
(Date:5/4/2016)... ... May 04, 2016 , ... Cirius, a provider of ... innovative Secure Messaging platform, which includes secure, private messaging, large file sharing, secure ... portfolio of patents around innovative features for securing, tracking, and controlling messages for ...
(Date:5/4/2016)... Camas, WA (PRWEB) , ... ... ... Agencies, a full service insurance provider serving families of Camas and Vancouver, ... The current campaign fundraises for the National Breast Cancer Foundation and their ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... is set to return to the esteemed Quaker Ridge Golf Club in Scarsdale, ...
(Date:5/4/2016)... New York, NY (PRWEB) , ... May 04, ... ... country’s leading private owners, developers and operators of commercial real estate proudly announced ... its 2015 Heart Health initiative. Team members portfolio-wide will continue Olshan Properties’ ...
Breaking Medicine News(10 mins):